Kawasaki disease thirty years on

Curr Opin Pediatr. 1998 Feb;10(1):24-33. doi: 10.1097/00008480-199802000-00006.


This year marks the 30th anniversary of the first description of Kawasaki disease. The disease has emerged as an important cause of acquired heart disease in children. The cause of Kawasaki disease remains unknown and this presents many problems in the diagnosis and management of the disease. This paper reviews recent publications on the pathogenesis, diagnosis, and the short- and long-term management of Kawasaki disease.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Aspirin / therapeutic use
  • Child
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Mucocutaneous Lymph Node Syndrome* / diagnosis
  • Mucocutaneous Lymph Node Syndrome* / etiology
  • Mucocutaneous Lymph Node Syndrome* / therapy
  • Prognosis


  • Anti-Inflammatory Agents, Non-Steroidal
  • Glucocorticoids
  • Immunoglobulins, Intravenous
  • Aspirin